68Ga-PSMA-11
Showing 1 - 25 of 5,019
Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
- 68Ga-P16-093
- 68Ga-PSMA-11
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 1, 2022
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
- 68Ga-PSMA-11
- 68Ga-P15-041
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,
Not yet recruiting
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- +2 more
- 68Ga-PSMA-11
- PET/CT or PET/MRI
-
Changsha, China
- +5 more
Apr 26, 2023
Prostate Cancer Trial (Radiopharmaceutical 68Ga-PSMA-11 PET/CT)
Not yet recruiting
- Prostate Cancer
- Radiopharmaceutical 68Ga-PSMA-11 PET/CT
- (no location specified)
Oct 12, 2022
Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)
Not yet recruiting
- Patients With Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA-617 PET scan
- (no location specified)
Nov 13, 2023
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
-
Houston, TexasHouston Methodist
Dec 8, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Prostate Cancer Trial in Bern (18F-PSMA-1007, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
- 18F-PSMA-1007
- 68Ga-PSMA-11
-
Bern, SwitzerlandInselspital, Universitätsspital Bern
Jul 4, 2022
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Aurora, Denver (Ga-PSMA-11)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Aurora, Colorado
- +1 more
Jul 28, 2022
Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission
Available
- Prostate Cancer
- +2 more
- 68Ga-PSMA-11
- Positron Emission Tomography/Computed Tomography
-
Dallas, TexasUT Southwestern Medical Center
Sep 27, 2022
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Prostate Cancer Trial in Stanford (68Ga RM2, 68Ga-PSMA-11, Investigational PET scanner coils and software)
Suspended
- Prostate Cancer
- 68Ga RM2
- +2 more
-
Stanford, CaliforniaStanford University
May 3, 2022
Prostate Cancer Trial in Montreal (68Ga-HBED-CC-PSMA PET/CT)
Enrolling by invitation
- Prostate Cancer
- 68Ga-HBED-CC-PSMA PET/CT
-
Montreal, Quebec, CanadaJewish General Hospital
Oct 24, 2022
Prostate Cancer Trial in Indianapolis (68Ga-PSMA-11 PET Scan)
Active, not recruiting
- Prostate Cancer
- 68Ga-PSMA-11 PET Scan
-
Indianapolis, IndianaIndiana University Health University Hospital
May 10, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Prostatic Tumors, Prostatic Tumors, Castration-Resistant Trial in New Orleans (68 Ga-PSMA-11 prepared using a PSMA-11 Sterile
Available
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- 68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold Kit
-
New Orleans, LouisianaTulane Medical Center
Apr 25, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- 68Ga-PSMA-11
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California San Francisco
Feb 27, 2022
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)
Recruiting
- Prostate Cancer
- PET/CT
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of China University of Science and
Jul 19, 2023
Prostate Adenocarcinoma Trial (68Ga-PSMA-11)
Available
- Prostate Adenocarcinoma
- 68Ga-PSMA-11
- (no location specified)
Jun 10, 2022